RBC Capital on Sangamo BioSciences (SGMO): 'hold being lifted is a clear positive'
Tweet Send to a Friend
RBC Capital analyst Luca Issi reiterated an Outperform rating and $22.00 price target on Sangamo BioSciences (NASDAQ: SGMO).The analyst comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
